Vita Therapeutics
PrivateLast Round
Series B
Oct 12, 2022
Total Funding Raised
$66M
Company Overview
Vita Therapeutics operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series B round in October 2022.
Vita Therapeutics is a biotechnology company that develops engineered cellular therapies using induced pluripotent stem cell (iPSC) technology to treat neuromuscular diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vita Therapeutics Comparables
Compare Vita Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 85% | |
| IPS HEART | 77% | |
| Century Therapeutics | 76% |
For institutional investors. Book with your work email.
Vita Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 12, 2022 | ||||
| Series A | Jun 23, 2021 | ||||
| Seed | Jun 26, 2020 | ||||
| Grant | Jun 5, 2020 | ||||
| Seed | Jan 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vita Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Seed |
| TEDCO | Series B, Seed |
| Early Light Ventures | Series A |
| Johns Hopkins Technology Ventures | Series A |
| SCM Lifescience | Series A |
| Solve FSHD | Series B |
| Maryland Stem Cell Research Fund | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
Launched a universal iPSC program for FSHD therapy.
- Oct 12, 2022
$31M round led by Cambrian Bio and Solve FSHD.
For institutional investors. Book with your work email.
Vita Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vita Therapeutics's valuation, stock price, and market status.
Is Vita Therapeutics a public or private company?
Vita Therapeutics is a private company.
What is the current stock price of Vita Therapeutics?
Vita Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vita Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vita Therapeutics worth (valuation)?
Valuation information for Vita Therapeutics is not publicly available.
Can I buy Vita Therapeutics stock?
Vita Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vita Therapeutics's last funding round?
Vita Therapeutics's most recent funding round was Series B on October 12, 2022.
Who are the main investors in Vita Therapeutics?
Key investors in Vita Therapeutics include Solve FSHD.
Will Vita Therapeutics IPO soon?
No public IPO plans have been announced for Vita Therapeutics.
How can I track Vita Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vita Therapeutics's shares on secondary markets.